Aligos Therapeutics Inc.

ALGS | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.01

+$0.52 (+9.47%)

Sep 22, 2026, 10:45 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-24.19M	-131.21M	-87.68M	-96.05M	-128.33M	-108.54M
Depreciation & Amortization	2.81M	2.62M	3.07M	3.68M	3.78M	3.33M
Stock-Based Compensation	5.04M	8.45M	12.65M	14.69M	13.46M	2.98M
Other Working Capital	-5.2M	-5.01M	-7.31M	-3.27M	-4.34M	16.19M
Other Non-Cash Items	-62.37M	44.35M	2.49M	-159K	86K	11.92M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.79M	-4.96M	-9.53M	-1.55M	-4.65M	16.06M
Operating Cash Flow	-82.5M	-80.74M	-79M	-79.39M	-115.66M	-74.26M
Capital Expenditures	-437K	-130K	-19K	-943K	-892K	-2.06M
Cash Acquisitions	n/a	n/a	n/a	n/a	-3.91M	n/a
Purchase of Investments	-164.89M	-108.15M	-11K	-104.27M	-19.09M	-45.28M
Sales Maturities Of Investments	127.5M	90M	45.01M	78.92M	23M	80.1M
Other Investing Acitivies	n/a	n/a	n/a	n/a	3.91M	n/a
Investing Cash Flow	-37.83M	-18.28M	44.98M	-26.29M	3.02M	32.76M
Debt Repayment	-14K	-83K	-96K	-61K	-79K	-58K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	70.98M	n/a	172K	-3.14M
Financial Cash Flow	101.64M	355K	88.33M	164K	78.68M	192.35M
Net Cash Flow	-18.69M	-98.67M	54.31M	-105.52M	-33.96M	150.84M
Free Cash Flow	-82.94M	-80.87M	-79.02M	-80.33M	-116.55M	-76.33M
Adj. Free Cash Flow	-87.98M	-89.33M	-91.67M	-95.03M	-130.01M	-79.3M
Maintenance CapEx	-437K	-130K	n/a	n/a	n/a	-2.06M
Growth CapEx	n/a	n/a	-19K	-943K	-892K	n/a
Owner Earnings	-82.94M	-80.87M	-79M	-79.39M	-115.66M	-76.33M